Trials / Sponsors / Wangxia LV
Wangxia LV
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCR Colorectal Cancer Metastatic | Phase 1 / Phase 2 | 2024-04-01 |